Breast Cancer Awareness Month Women are encouraged to perform self-breast exams and keep up with mammography for early detection

October 20, 2021

Every year, people around the world show their support for those affected by breast cancer. The month of October sees international campaigns shining......

QIAGEN Launches Novel QIAreach QuantiFERON-TB Tuberculosis Test for High-Burden Regions

October 20, 2021

• QIAGEN leverages QuantiFERON®-TB technology to advance global efforts...
  Continue Reading >

Boehringer Ingelheim and Partners to Accelerate Development of First-In-Class Gene Therapy for Patients with Cystic Fibrosis

October 19, 2021

- Boehringer Ingelheim, IP Group, the UK Cystic Fibrosis Gene Therapy Consortium (GTC, consisting of researchers from Imperial College London and......

St. Regis launches Pinktober campaign in aid of Al Jalila

October 18, 2021

The St. Regis Abu Dhabi, The St. Regis Saadiyat Island Resort and Al Wathba, a Luxury Collection Desert Resort & Spa, have launched initiatives......

Rhizen Pharmaceuticals AG Announces First Patient Dosing in a Phase II Study of Tenalisib (RP6530) in Locally Advanced or Metastatic Breast Cancer Patients

October 14, 2021

• Rhizen Pharma commences dosing in a phase II trial to evaluate Tenalisib...
  Continue Reading >

SMOORE Wins a 2021 MUSE Design Award for its Disposable Vape TA15

October 13, 2021

SMOORE, a global leader in offering vaping technology solutions, today announced that its flagship tech brand, FEELM, has received a gold award in......

New Real-World MAVENCLAD® Data Show Sustained Effectiveness and Benefit on Quality-of-Life Measures in RMS Patients

October 13, 2021

• New data presented at ECTRIMS 2021 highlight improvement in measures of...
  Continue Reading >

The Rise of Plastic Surgery and Cosmetic Procedures Post-Pandemic

October 11, 2021

As the Covid-19 global pandemic winds down, a sharp spike in requests for cosmetic procedures has been observed, as life slowly returns back to normal.......

FDA Advisory Committee Recommends Use of Investigational Drug Maribavir (TAK-620) to Treat Post-Transplant Recipients with Cytomegalovirus (CMV) Infection and Disease Refractory to Treatment With or Without Resistance

October 8, 2021

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the U.S. Food and Drug Administration (FDA) Antimicrobial......

SpeeDx Build Further Coverage in SARS-CoV-2 Genotyping Reagent Portfolio

October 7, 2021

SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, have further expanded their product line of research reagents for COVID-19......